Publicaciones en las que colabora con CELSO ARANGO LÓPEZ (63)

2024

  1. School bullying in children and adolescents with neurodevelopmental and psychiatric conditions: a systematic review and meta-analysis

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 2, pp. 122-134

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

2022

  1. Leukocyte telomere length in patients with schizophrenia and related disorders: a meta-analysis of case-control studies

    Molecular Psychiatry, Vol. 27, Núm. 7, pp. 2968-2975

  2. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

    Molecular Autism, Vol. 13, Núm. 1

  3. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 2, pp. 74-87

2021

  1. Assessment of School Anti-Bullying Interventions: A Meta-analysis of Randomized Clinical Trials

    JAMA Pediatrics, Vol. 175, Núm. 1, pp. 44-45

  2. Fronto-parietal gray matter volume loss is associated with decreased working memory performance in adolescents with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  3. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4496-4510

  4. Humanization in mental health plans in Spain

    Revista de Psiquiatria y Salud Mental

  5. Methodologic and Reporting Issues in Published Meta-analysis - Reply

    JAMA Pediatrics

  6. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

    Translational Psychiatry, Vol. 11, Núm. 1

  7. The role of depression in the prediction of a “late” remission in first-episode psychosis: An analysis of the OPTiMiSE study

    Schizophrenia Research, Vol. 231, pp. 100-107

  8. The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 11

2020

  1. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): Systematic review and meta-regression analysis

    Molecular Autism, Vol. 11, Núm. 1

  2. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome

    Nature Medicine, Vol. 26, Núm. 12, pp. 1912-1918

2019

  1. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis

    Pediatrics, Vol. 144, Núm. 5

  2. Neuroanatomical deficits shared by youth with autism spectrum disorders and psychotic disorders

    Human Brain Mapping, Vol. 40, Núm. 5, pp. 1643-1653

  3. Oxidative stress and inflammation in first-episode psychosis: A Systematic Review and Meta-analysis

    Schizophrenia Bulletin, Vol. 45, Núm. 4, pp. 742-751

  4. Predictors of placebo response in pharmacological clinical trials of negative symptoms in schizophrenia: A meta-regression analysis

    Schizophrenia Bulletin, Vol. 45, Núm. 1, pp. 57-68